{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"CHEK2, a tumor suppressor and intracellular kinase, is altered in various cancer types. Germline mutations of CHEK2 are associated with an increased risk of certain cancers including breast, prostate and colorectal cancers.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"03/13/2018",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[]
    },
    "description":"",
    "knownEffect":"Unknown"
  },
  "oncogenic":"Unknown",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"K464N",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":11200,
    "hgvs":"22:g.28694101C>A",
    "hugoSymbol":"CHEK2",
    "id":null,
    "proteinEnd":464,
    "proteinStart":464,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The biologic significance of the CHEK2 K464N mutation is unknown.",
  "vus":false
}